NCT00187044View on ClinicalTrials.gov

Evaluation of the Safety of a Polyvalent Virus in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
HIV InfectionHuman Immunodeficiency Virus
Interventions
BIOLOGICAL

PolyEnv1 vaccine

administered subcutaneously as 10\*7 pfu in 0.8 mL

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT00187044 - Evaluation of the Safety of a Polyvalent Virus in Healthy Adults | Biotech Hunter | Biotech Hunter